IN HIGHLY REFRACTORY ULCERATIVE COLITIS PATIENTS, USTEKINUMAB IS A GOOD THERAPEUTIC OPTION
ALEJANDRO MÍNGUEZ SABATER 1
Marisa Iborra
Carlos Soutullo Castiñeiras
Marta Gimeno
Guillermo Bastida
Mariam Aguas
Elena Cerrillo
Esteban Sáez González
Alejandro Garrido
Javier Bordetas
Pilar Nos
1 Hospital Universitario y Politécnico La Fe, Gastroenterology Department, Valencia, Spain
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]